Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)

Contemporary Clinical Trials

Volumn 47, Issue , 2016, Pages 235-243

  Bassuk, Shari S ^a   Manson, JoAnn E ^a,b   Lee, I Min ^a,b   Cook, Nancy R ^a,b   Christen, William G ^a   Bubes, Vadim Y ^a   Gordon, David S ^a   Copeland, Trisha ^a   Friedenberg, Georgina ^a   D'Agostino, Denise M ^a   Ridge, Claire Y ^a   MacFadyen, Jean G ^a   Kalan, Kate ^a   Buring, Julie E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer; Cardiovascular disease; Omega 3 fatty acids; Primary prevention; Randomized clinical trial; Vitamin D

Indexed keywords

COLECALCIFEROL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; DRUG COMBINATION; OMEGA 3 ACID ETHYL ESTER; VITAMIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BEHAVIOR; BLOOD SAMPLING; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIMARY PREVENTION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOL; DIETARY SUPPLEMENT; DRUG COMBINATION; METHODOLOGY; MIDDLE AGED; NEOPLASMS; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLECALCIFEROL; CLINICAL PROTOCOLS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; PRIMARY PREVENTION; RESEARCH DESIGN; VITAMINS;

EID: 84957568124     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.12.022     Document Type: Article

References (47)

1. Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D 2011, The National Academies Press, Washington DC.
2. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757.
3. Greider K. Has vitamin D been oversold?. AARP Bulletin July 5, 2012, (Available at: http://www.aarp.org/health/drugs-supplements/info-07-2012/how-much-vitamin-d-is-enough.1.html. Accessed October 16, 2015).
4. Kupferschmidt K. Uncertain verdict as vitamin D goes on trial. Science 2012, 337(6101):1476-1478.
5. Bailey R.L., Gahche J.J., Miller P.E., Thomas P.R., Dwyer J.T. Why US adults use dietary supplements. JAMA Intern. Med. 2013, 173(5):355-361.
6. Manson J.E., Bassuk S.S., Lee I-M., Cook N.R., Albert M.A., Gordon D., et al. The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 2012, 33(1):159-171.
7. Manson J.E., Bassuk S.S. Vitamin D research and clinical practice: at a crossroads. JAMA 2015, 313(13):1311-1312.
8. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326(7387):469.
9. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85(6):1586-1591.
10. Lappe J.M., Heaney R.P. Calcium supplementation: results may not be generalisable. BMJ 2008, 336(7641):403. (author reply 4).
11. Wactawski-Wende J., Kotchen J.M., Anderson G.L., Assaf A.R., Brunner R.L., O'Sullivan M.J., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 2006, 354(7):684-696.
12. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., et al. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354(7):669-683.
13. Chlebowski R.T., Johnson K.C., Kooperberg C., Pettinger M., Wactawski-Wende J., Rohan T., et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J. Natl. Cancer Inst. 2008, 100(22):1581-1591.
14. 3 and/or calcium (RECORD trial). J. Clin. Endocrinol. Metab. 2012, 97(2):614-622.
15. Chung M., Balk E.M., Brendel M., Ip S., Lau J., Lee J., et al. Vitamin D and calcium: a systematic review of health outcomes. Evidence Report No. 183 (Prepared by the Tufts Evidence-based Practice Center under Contract No. HHSA 290-2007-10055-I). AHRQ Publication No. 09-E015 2009, Agency for Healthcare Research and Quality, Rockville MD, (Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/vitadcal/vitadcal.pdf. Accessed July 20, 2015).
16. Elamin M.B., Abu Elnour N.O., Elamin K.B., Fatourechi M.M., Alkatib A.A., Almandoz J.P., et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96(7):1931-1942.
17. Keum N., Giovannucci E. Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br. J. Cancer 2014, 111(5):976-980.
18. Theodoratou E., Tzoulaki I., Zgaga L., Ioannidis J.P. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014, 348:g2035.
19. Welsh P., Sattar N. Vitamin D and chronic disease prevention. BMJ 2014, 348:g2280.
20. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Krstic G., Wetterslev J., et al. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst. Rev. 2014, 6.
21. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354(9177):447-455.
22. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369(9567):1090-1098.
23. GISSI-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9645):1223-1230.
24. Roncaglioni M.C., Tombesi M., Avanzini F., Barlera S., Caimi V., Longoni P., et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N. Engl. J. Med. 2013, 368(19):1800-1808.
25. Bosch J., Gerstein H.C., Dagenais G.R., Diaz R., Dyal L., Jung H., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 2012, 367(4):309-318.
26. Kromhout D., Giltay E.J., Geleijnse J.M. For the Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med. 2010, 363(21):2015-2026.
27. Galan P., Kesse-Guyot E., Czernichow S., Briancon S., Blacher J., Hercberg S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010, 341:c6273.
28. Rauch B., Schiele R., Schneider S., Diller F., Victor N., Gohlke H., et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010, 122(21):2152-2159.
29. Neale R. D-health trial. Australian New Zealand Clinical Trials Registry identifier: ACTRN12613000743763. (Available at: Accessed August 13, 2015). https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364534&isClinicalTrial=False.
30. Neale R. D-Health website. / (Accessed August 13, 2015). http://dhealth.qimrberghofer.edu.au/.
31. Peto J. Vitamin D and longevity (ViDAL) Trial: randomised feasibility study. ISRCTN identifier: ISRCTN46328341. (Available at: Accessed July 20, 2015). http://www.controlled-trials.com/ISRCTN46328341.
32. Peto J. ViDAL website. / (Accessed August 13, 2015). http://vidal.lshtm.ac.uk/.
33. LeBoff M.S., Yue A.Y., Copeland T., Cook N.R., Buring J.E., Manson J.E. VITAL-bone health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). Contemp. Clin. Trials 2015, 41:259-268.
34. Rimm E.B., Giovannucci E.L., Stampfer M.J., Colditz G.A., Litin L.B., Willett W.C. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am. J. Epidemiol. 1992, 135(10):1114-1126.
35. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). Bridged-race population estimates, U.S. July 1 resident population by state, county, age, sex, bridged-race, and Hispanic origin. Compiled from 1990 to 1999 bridged-race intercensal population estimates (released by NCHS on 7/26/2004); revised bridged-race 2000-2009 intercensal population estimates (released by NCHS on 10/26/2012); and bridged-race Vintage 2013 (2010-2013) postcensal population estimates (released by NCHS on 6/26/2014). (Available on CDC WONDER Online Database. Accessed at on June 9, 2015). http://wonder.cdc.gov/bridged-race-v2013.html.
36. Census U.S. Current Population Survey, Annual Social and Economic Supplement 2012, (Internet release date 2013. Accessed at http://www.census.gov/population/age/data/2012.html on June 16, 2015).
37. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497.
38. Centers for Disease Control and Prevention Early Release of Selected Estimates Based on Data from the January-September 2013 National Health Interview Survey March 27, 2014, (Available at: www.cdc.gov/nchs/nhis/released201403.htm Accessed July 17, 2015).
39. National Center for Health Statistics Health, United States, 2014: With Special Feature on Adults Aged 55-64 2015, National Center for Health Statistics, Hyattsville MD, (Available at: http://www.cdc.gov/nchs/data/hus/hus14.pdf. Accessed July 20, 2015).
40. Harris C.D., Watson K.B., Carlson S.A., Fulton J.E., Dorn J.M., Elam-Evans L. Adult participation in aerobic and muscle-strengthening physical activities-United States, 2011. MMWR 2013, 62(17):326-330.
41. Nicastro H.L., Bailey R.L., Dodd K.W. Using 2 assessment methods may better describe dietary supplement intakes in the United States. J. Nutr. 2015, 145(7):1630-1634.
42. Sprague B.L., Trentham-Dietz A., Cronin K.A. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet. Gynecol. 2012, 120(3):595-603.
43. U.S.Department of Agriculture Scientific Report of the 2015 Dietary Guidelines Advisory Committee 2015, (Available at: http://www.health.gov/dietaryguidelines/2015-scientific-report/. Accessed July 20, 2015).
44. Gu Q., Paulose-Ram R., Burt V.L., Kit B.K. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. NCHS Data Brief, No. 177 2014, Hyattsville MD, National Center for Health Statistics, (Available at: http://www.cdc.gov/nchs/data/databriefs/db177.pdf. Accessed June 21, 2015).
45. Sebastian R.S., Goldman J.D., Wilkinson Enns C., RP L.C. Fluid milk consumption in the United States: what we eat in America, NHANES 2005-2006. Food Surveys Research Group Dietary Data Brief No. 3 September 2010, (Available at: http://www.ars.usda.gov/SP2UserFiles/Place/80400530/pdf/DBrief/3_milk_consumption_0506.pdf. Accessed July 20, 2015).
46. American Cancer Society Cancer Facts & Figures for African Americans 2013-2014 2013, American Cancer Society, Atlanta, (Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036921.pdf. Accessed July 20, 2015).
47. Harris S.S. Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans?. Am. J. Clin. Nutr. 2011, 93(5):1175S-1178S.